Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Largecap Value Opp Alphadex First Trust | FTA | Nov 20, 2024 | 81.02 | +0.35 |
Largo | LGO | Nov 20, 2024 | 2.00 | -1.96 |
Larimar Therapeutics | LRMR | Nov 20, 2024 | 6.08 | -4.70 |
Las Vegas Sands | LVS | Nov 20, 2024 | 49.91 | +1.48 |
Laser Photonics | LASE | Nov 20, 2024 | 5.58 | +5.28 |
Latham Group | SWIM | Nov 20, 2024 | 5.87 | +2.09 |
Latin America Alphadex First Trust | FLN | Nov 20, 2024 | 16.75 | -0.68 |
Lattice Semiconductor | LSCC | Nov 20, 2024 | 50.75 | +4.47 |
Launch One Acquisition | LPAA | Nov 20, 2024 | 10.00 | 0.00 |
Launch One Acquisition | LPAAU | Nov 20, 2024 | 10.05 | 0.00 |
Launch Two Acquisition Units | LPBBU | Nov 20, 2024 | 9.98 | 0.00 |
Laureate Education | LAUR | Nov 20, 2024 | 18.88 | +0.59 |
LAVA Therapeutics | LVTX | Nov 20, 2024 | 1.52 | -2.25 |
Lavoro | LVRO | Nov 20, 2024 | 4.77 | +3.47 |
Lazard A | LAZ | Nov 20, 2024 | 54.95 | -0.09 |
Lazard Global Total Return and Income Fund | LGI | Nov 20, 2024 | 16.37 | -0.49 |
Lazydays | GORV | Nov 20, 2024 | 0.93 | +3.32 |
LCI Industries | LCII | Nov 20, 2024 | 115.64 | +1.50 |
LCNB | LCNB | Nov 20, 2024 | 16.95 | -0.53 |
Lead Real Estate ADR | LRE | Nov 20, 2024 | 2.13 | -2.74 |
Leafly | LFLY | Nov 20, 2024 | 1.58 | -7.60 |
Leap Therapeutics | LPTX | Nov 20, 2024 | 2.59 | -4.07 |
Lear | LEA | Nov 20, 2024 | 93.56 | +0.66 |
LeddarTech | LDTC | Nov 20, 2024 | 0.30 | -3.68 |
Lee Enterprises | LEE | Nov 20, 2024 | 16.09 | +3.67 |
Legacy Housing | LEGH | Nov 20, 2024 | 25.30 | +0.40 |
LegalZoom.com | LZ | Nov 20, 2024 | 7.63 | +1.19 |
Legato Merger III | LEGT | Nov 20, 2024 | 10.27 | -0.06 |
Legend Biotech ADR | LEGN | Nov 20, 2024 | 40.14 | +4.53 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Nov 20, 2024 | 40.12 | +0.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.